日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Shortened High-dose Palliative Radiotherapy for Lung Cancer (SHiP-Rt): protocol for a single-arm, multicentre, phase II study

缩短疗程的高剂量姑息性肺癌放疗(SHiP-Rt):单臂、多中心 II 期研究方案

Shrimali, Raj Kumar; Griffin, Ellanna; Sturgess, Vicky; Jones, Matthew; Hiller, Louise; Rogers, Jane; Hamilton, Joanna; Peebles, Charles; Jones, Bleddyn; Dunn, Janet

Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Review

Claudin 18.2阳性、HER2阴性、局部晚期不可切除或转移性胃或胃食管交界处腺癌患者的症状负担和医疗资源利用情况:一项回顾性研究

Sewastjanow-Silva, Matheus; Oh, Mok; Chang, Lawrence; Ganguli, Arijit; Rogers, Jane E; Waters, Rebecca E; Vicentini, Ernesto Rosa; Yamashita, Kohei; Totev, Todor I; Wu, Eric Q; Yang, Hongbo; Iwata, Kenneth; Ajani, Jaffer A

Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer

转移性肛门癌患者接受免疫检查点阻断治疗后生存率相关的临床病理特征

Peddireddy, Arjun S; Huey, Ryan; Wolff, Robert A; Lin, Kangyu; Mitchell, Jocelyn; Scofield, Lisa; Jacob, Sophia; Nguyen, Diem V; Rogers, Jane; Portier, Shaelynn; Foo, Wai Chin; Eng, Cathy; Morris, Van K

Evolution of Therapeutics for Locally Advanced Upper Gastrointestinal Adenocarcinoma

局部晚期上消化道腺癌治疗的演变

Li, Jenny J; Rogers, Jane E; Waters, Rebecca E; Gan, Qiong; Blum Murphy, Mariela; Ajani, Jaffer A

Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma

抗Claudin 18.2抗体在胃腺癌中的未来前景

Covert, Wendy M; Rogers, Jane E

SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel

SMARCA4 突变在胃食管腺癌中的检测:一项基于二代测序技术的观察性研究

Yamashita, Kohei; Sewastjanow-Silva, Matheus; Yoshimura, Katsuhiro; Rogers, Jane E; Rosa Vicentini, Ernesto; Pool Pizzi, Melissa; Fan, Yibo; Zou, Gengyi; Li, Jenny J; Blum Murphy, Mariela; Gan, Qiong; Waters, Rebecca E; Wang, Linghua; Ajani, Jaffer A

Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study

局部食管或胃食管交界处腺癌切除术前后化疗联合阿特珠单抗治疗:一项 I/II 期单臂研究

Sewastjanow-Silva, Matheus; Xiao, Lianchun; Gonzalez, Graciela N; Wang, Xuemei; Hofstetter, Wayne; Swisher, Stephen; Mehran, Reza; Sepesi, Boris; Bhutani, Manoop S; Weston, Brian; Coronel, Emmanuel; Waters, Rebecca E; Rogers, Jane E; Smith, Jackie; Lyons, Larry; Reilly, Norelle; Yao, James C; Ajani, Jaffer A; Murphy, Mariela Blum

Evidence to Date on the Therapeutic Potential of Zolbetuximab in Advanced Gastroesophageal Adenocarcinoma

佐贝妥昔单抗治疗晚期胃食管腺癌的疗效及现有证据

Rogers, Jane E; Ajani, Jaffer

Therapeutic Advances in the Treatment of Gastroesophageal Cancers

胃食管癌治疗进展

Li, Jenny J; Rogers, Jane E; Yamashita, Kohei; Waters, Rebecca E; Blum Murphy, Mariela; Ajani, Jaffer A

Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target

人表皮生长因子受体-2胃腺癌:拓展针对已知靶点的治疗

Rogers, Jane E; Yamashita, Kohei; Sewastjanow-Silva, Matheus; Trail, Allison; Waters, Rebecca E; Ajani, Jaffer